PURPOSE: The purpose of the study is to assess validity, reliability and factor structure of the Italian version of Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in patients suffering from chronic migraine (CM) with a history of medication overuse (MO). METHODS: Patients were enrolled at hospital admission for withdrawal from MO. Factor analysis was used to confirm the latent structure of the MSQ. Reliability was measured with Cronbach's alpha coefficient, item-total correlation and inter-item correlation. Construct validity was assessed with Pearson's coefficient and known-group analysis. RESULTS: The three-factor structure is basically confirmed. Cronbach's alpha varied between 0.85 and 0.92; item-total correlations were on average higher than 0.70; average inter-item correlation ranged between 0.63 and 0.65. Correlations were all significant; known-group analysis shows that MSQ score was lower consistently with disease severity. CONCLUSIONS: Our findings confirm the factor structure, reliability and validity of the MSQ and expand results of previous validation studies to the Italian language and to a group of patients with severe CM requiring withdrawal treatment for MO.
PURPOSE: The purpose of the study is to assess validity, reliability and factor structure of the Italian version of Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in patients suffering from chronic migraine (CM) with a history of medication overuse (MO). METHODS:Patients were enrolled at hospital admission for withdrawal from MO. Factor analysis was used to confirm the latent structure of the MSQ. Reliability was measured with Cronbach's alpha coefficient, item-total correlation and inter-item correlation. Construct validity was assessed with Pearson's coefficient and known-group analysis. RESULTS: The three-factor structure is basically confirmed. Cronbach's alpha varied between 0.85 and 0.92; item-total correlations were on average higher than 0.70; average inter-item correlation ranged between 0.63 and 0.65. Correlations were all significant; known-group analysis shows that MSQ score was lower consistently with disease severity. CONCLUSIONS: Our findings confirm the factor structure, reliability and validity of the MSQ and expand results of previous validation studies to the Italian language and to a group of patients with severe CM requiring withdrawal treatment for MO.
Authors: P Tfelt-Hansen; G Block; C Dahlöf; H C Diener; M D Ferrari; P J Goadsby; V Guidetti; B Jones; R B Lipton; H Massiou; C Meinert; G Sandrini; T Steiner; P B Winter Journal: Cephalalgia Date: 2000-11 Impact factor: 6.292
Authors: T Bedirhan Ustün; Somnath Chatterji; Nenad Kostanjsek; Jürgen Rehm; Cille Kennedy; Joanne Epping-Jordan; Shekhar Saxena; Michael von Korff; Charles Pull Journal: Bull World Health Organ Date: 2010-05-20 Impact factor: 9.408
Authors: R B Lipton; S F Varon; B Grosberg; P J McAllister; F Freitag; S K Aurora; D W Dodick; S D Silberstein; H C Diener; R E DeGryse; M E Nolan; C C Turkel Journal: Neurology Date: 2011-09-28 Impact factor: 9.910
Authors: M Linde; A Gustavsson; L J Stovner; T J Steiner; J Barré; Z Katsarava; J M Lainez; C Lampl; M Lantéri-Minet; D Rastenyte; E Ruiz de la Torre; C Tassorelli; C Andrée Journal: Eur J Neurol Date: 2011-12-05 Impact factor: 6.089
Authors: Kerstin Luedtke; Annika Basener; Stephanie Bedei; Rene Castien; Aleksander Chaibi; Deborah Falla; Cesar Fernández-de-Las-Peñas; Mirja Gustafsson; Toby Hall; Gwen Jull; Peter Kropp; Bjarne K Madsen; Benjamin Schaefer; Elizabeth Seng; Claudia Steen; Peter Tuchin; Harry von Piekartz; Bettina Wollesen Journal: BMJ Open Date: 2020-02-12 Impact factor: 2.692
Authors: Alberto Raggi; Barbara Corso; Nadia Minicuci; Rui Quintas; Davide Sattin; Laura De Torres; Somnath Chatterji; Giovanni Battista Frisoni; Josep Maria Haro; Seppo Koskinen; Andrea Martinuzzi; Marta Miret; Beata Tobiasz-Adamczyk; Matilde Leonardi Journal: PLoS One Date: 2016-07-19 Impact factor: 3.240